Hovione is an international reference in the pharmaceutical industry. Founded in Portugal in 1959, with an international outlook that was established from its early years, the company has set itself apart through the science and technology it develops, as well as through its determination to find solutions to complex challenges.
In a sector as demanding as pharmaceuticals, Hovione has continuously invested in science, technology and innovation, enabling the company to expand its capabilities, which now encompass the production of active pharmaceutical ingredients, particle engineering and drug product manufacturing. The expansion of its Loures facility and the establishment of manufacturing sites in Macau, the United States and Ireland have brought the company closer to its customers and created an industrial network with global responsiveness.
